Category Archives: Public Policy

Latest From Public Policy

Patent Docs Highlights the BIO IPDx Symposium

shutterstock_10020697

Patent Docs recently highlighted McDonnell Boehnen Hulbert & Berghoff’s (MBHB) panel at BIO’s IP and Diagnostics Symposium (IPDx).  Moderated by Donald Zuhn at MBHB, panelists from MBHB, Roche Diagnostics, and the USPTO discussed the impact of the Myriad decision on obtaining patent protection for genetic diagnostics.  The panel concluded the following: “While there was agreement that the Myriad holding is not limited to human DNA, there was spirited disagreement regarding its long-term impact on patents claiming naturally Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

BioOhio Selects New Leadership

lewis-john250

John Lewis has been promoted to CEO of BioOhio, the biological sciences trade organization, recognized as BIO’s affiliated state organization in Ohio. John has been with BioOhio for the last twelve years and has been instrumental to its highly successful efforts to grow the biotech industry in the state. Earlier this year, BioOhio’s previous long-serving head, Tony Dennis, retired. Under Tony’s 11-year leadership, BioOhio helped elevate Ohio into top-tier ranks amongst virtually all bioscience industry Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: ,

The Hill: Innovation-focused tax reform for U.S. global competitiveness

DC in Fall

The Hill Blog published an op-ed by Geoff Davis on ‘Innovation-focused tax reform for U.S. global competitiveness.’ Davis, a former member of the House Ways & Means Committee, which has responsibility for writing our nation’s tax laws,  urges policymakers to support innovative, research-intensive businesses by encouraging private investment as they move towards tax reform. As he states, “If the U.S. is to remain competitive in the global economy, we need to make sure there are policies Read More >

Business and Investments, Public Policy  |  Leave a comment  |  Email This Post
Tags: , , ,

BIO IP & Diagnostics Symposium

Final IPDX logo

BIO’s IP & Diagnostics Symposium (BIO IPDX) will review the current patent law landscape and evaluate the impact on both the genetic diagnostics and biopharmaceutical sectors. The program will review IP issues for both diagnostics generally and companion diagnostics. The program will also explore some of the potential regulatory dimensions. BIO aims to use this event to inform industry and government alike on how to move the science forward in the current climate. Where & Read More >

Patently BIOtech  |  Leave a comment  |  Email This Post
Tags: , , , ,

The Pivotal Role the Public Market Plays in Financing R&D

KennethMoch-Chimerix

Growing innovators are the heart of our industry. Biotech small businesses face a dual struggle – the daily challenge of running a growing company combined with the roadblocks intrinsic to groundbreaking scientific advancement. Innovative companies must overcome capital formation barriers in order to fund their next generation R&D.  The financing challenges that emerging biotechs face are unique, but we have the potential to save lives and treat patients in desperate need of hope. Today, I Read More >

Public Policy  |  Leave a comment  |  Email This Post
Tags: , , , , ,